Results 71 to 80 of about 11,910 (159)
DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer. [PDF]
Purpose The aim of this review was to evaluate the existing evidence for radiotherapy for brain metastases in breast cancer patients and provide recommendations for the use of radiotherapy for brain metastases and leptomeningeal carcinomatosis. Materials
Harms, Wolfgang +23 more
core +2 more sources
Leptomeningeal carcinomatosis secondary to metastasic pancreatic adenocarcinoma. Case report [PDF]
, 2020 Pancreatic cancer is a common malignancy. Metastases to the central nervous system are extremely rare and have been described predominantly as focal brain lesions.
Mayner-Tresol, Gabriel +1 more
core +1 more source
Recent Advancements of Treatment for Leptomeningeal Carcinomatosis
Journal of Korean Neurosurgical Society, 2015 Treatment of Leptomeningeal carcinomatosis (LMC) from solid cancers has not advanced noticeably since the introduction of intra-cerebrospinal fluid (CSF) chemotherapy in the 1970's. The marginal survival benefit and difficulty of intrathecal chemotherapy injection has hindered its wide spread use.
Gwak, Ho-Shin +5 more
openaire +2 more sources
IJU Case Reports, Volume 9, Issue 1, January 2026.ABSTRACT Introduction Multiple cranial neuropathy is a rare manifestation of immune‐related adverse events. To date, no cases have been reported during immune checkpoint blockade for metastatic renal cell carcinoma. This report describes a case of multiple cranial neuropathy that developed during lenvatinib and pembrolizumab combination therapy.
Hideyuki Minagawa +9 more
wiley +1 more source
, 2005 Item does not contain fulltextA 1-year complete remission could be achieved with high-dose systemic chemotherapy in a 33-year-old patient with relapsed germ cell tumor presenting with leptomeningeal carcinomatosis (LC).
Smilde, T.J. +3 more
core +1 more source
Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
, 2022 A 75-year-old male presented with lower back pain, bilateral lower extremity weakness, decreased sensation to vibration and proprioception in lower extremities, anemia, and vitamin B12 deficiency.
Singh, Leena +8 more
core +1 more source
Frontiers in Neurology, 2012 Primary central nervous system (CNS) teratomas are rare tumors that consist of all three germ cell layers. We describe a young man with a primary malignant CNS teratocarcinoma presenting as leptomeningeal carcinomatosis.
Danilo eVitorovic +4 more
doaj +1 more source
Leptomeningeal Carcinomatosis in Solid Tumors ; Clinical Manifestation and Treatment
, 2001 Purpose: Leptomeningeal carcinomatosis occurs in about 5% of patients with solid tumor and is being diagnosed with increasing frequency as patients live longer and as neuro-imaging studies improve.
정희철, 정현철, 노재경
core
Intrathecal Therapy Options for Meningeal Carcinomatosis [PDF]
Around 5 percent of all patients with metastatic breast cancer go on to develop distant metastases in the meninges, also known as meningeal carcinomatosis. The median survival of these patients is between 3.5 and 4.5 months.
Marowsky, Madeleine +5 more
core +1 more source